HOME › DRUGS › EPTIFIBATIDE
ACTIVE SUBSTANCE / INN

EPTIFIBATIDE

Brand name(s): Integrilin, INTEGRILIN, Eptifibatide Accord, EPTIFIBATIDE
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA203258
ANDA204362
ACTIVE SUBSTANCE
Eptifibatide
REGULATORS
FDA · EMA
SPONSORS / MAH
MYLAN LABS LTD, USV, GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
EPTIFIBATIDEANDA204362USVDiscontinued
EPTIFIBATIDEANDA203258MYLAN LABS LTDPrescription
INTEGRILINNDA020718MSD SUB MERCKDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Eptifibatide AccordAccord Healthcare S.L.U.Authorised11/01/2016Myocardial Infarction
IntegrilinGlaxoSmithKline Trading Services LimitedAuthorised01/07/1999Angina, Unstable;Myocardial Infarction

FULL INTELLIGENCE ON EPTIFIBATIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →